NCT03845270 2023-12-19
R2D2
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Completed
Clinical Trials
4 trialsNCT02507375 2015-10-16
A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche
Phase 1 Completed
NCT00063154 2015-07-07
Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy
Genentech, Inc.
Phase 2 Completed
NCT00855894 2013-05-21
PENGUIN
Genentech, Inc.
Phase 2 Completed